ClinConnect ClinConnect Logo
Search / Trial NCT07008040

Assessing the Effect of the Silver Dressing on Surgical Site Infections in Adult Patients Post Cardiac Surgery: a Single Center Randomized Control Trial

Launched by KING FAISAL SPECIALIST HOSPITAL & RESEARCH CENTER · May 29, 2025

Trial Information

Current as of November 14, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

This trial is testing whether using a silver dressing on chest wounds after adult cardiac surgery reduces surgical site infections (SSIs) within 30 days after the operation, compared with standard foam dressings. It’s a randomized, open-label study (participants and care teams will know which dressing is used) being conducted at King Faisal Specialist Hospital & Research Center in Jeddah, Saudi Arabia. About 145 adults are expected to enroll, and patients will be followed in the ICU, CCU, or cardiology telemetry units to see whether the wound becomes infected.

Eligibility and participation are straightforward: adults 18 or older who are scheduled for cardiac surgery requiring a sternotomy can join, provided they do not have an existing infection and are not on systemic antibiotics beyond perioperative prophylaxis. Exclusions include redo surgeries, open-chest status, emergency procedures, use of ECMO, very heavy bleeding, or an allergy to silver dressings. If enrolled, participants are randomly assigned to receive either the silver dressing or the standard dressing and will be observed for 30 days post-surgery using a simple checklist. The study aims to improve wound care in heart surgery, with completion anticipated by the end of 2026; no personal data will be shared publicly.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients 18 years of age and older are scheduled for cardiac surgery requiring a sternotomy incision.
  • Exclusion criteria Presence of a concurrent infection and any systemic antibiotic other than those used for perioperative prophylaxis.
  • Patients who died without an infection within thirty days following surgery. Patients who had undergone another procedure through the same incision(s) within a year after enrollment in this study.
  • Patients who are a redo- such as needing debridement or an infection. Patients who have an open chest Patients on ECHMO Patients excessively bleeding Patients who require the surgery as an emergency Patients with a known allergy to silver dressings
  • -

About King Faisal Specialist Hospital & Research Center

King Faisal Specialist Hospital & Research Center (KFSH&RC) is a leading medical institution in Saudi Arabia, dedicated to providing advanced healthcare services, conducting pioneering research, and training healthcare professionals. Founded in 1975, KFSH&RC specializes in comprehensive patient care across various disciplines, including oncology, organ transplantation, and genetics. The center is recognized for its commitment to clinical excellence and innovation, actively participating in clinical trials to enhance treatment options and improve patient outcomes. With state-of-the-art facilities and a multidisciplinary team of experts, KFSH&RC plays a pivotal role in advancing medical knowledge and improving healthcare standards in the region and beyond.

Locations

Jeddah, Saudi Arabia

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported